KJP Posted December 24, 2016 Share Posted December 24, 2016 2016 Financials are out: http://ftp.pdrx.com/docs/2016AuditorsReport.pdf Link to comment Share on other sites More sharing options...
wachtwoord Posted December 24, 2016 Share Posted December 24, 2016 2016 Financials are out: http://ftp.pdrx.com/docs/2016AuditorsReport.pdf At first glance it looks like things haven't improved since last year. Link to comment Share on other sites More sharing options...
KJP Posted December 24, 2016 Share Posted December 24, 2016 At first glance it looks like things haven't improved since last year. Improved for whom? Management's cash bonus is based on "a percentage of gross sales" (see Note E to audited financials) so things appear to have improved a bit for them. Because of management's poor capital allocation, this is turning into a cash box that generates single-digit ROE. Management also has no reason to care about the stock price until they choose to sell, so I wouldn't expect any changes until then. Link to comment Share on other sites More sharing options...
Green King Posted December 24, 2016 Share Posted December 24, 2016 At first glance it looks like things haven't improved since last year. Improved for whom? Management's cash bonus is based on "a percentage of gross sales" (see Note E to audited financials) so things appear to have improved a bit for them. Because of management's poor capital allocation, this is turning into a cash box that generates single-digit ROE. Management also has no reason to care about the stock price until they choose to sell, so I wouldn't expect any changes until then. +1 Earning 5% on current assets less debt. This business is worth more dead than alive. Link to comment Share on other sites More sharing options...
writser Posted December 25, 2016 Share Posted December 25, 2016 Yes, that's the bear case. The bull case is that you get the business for free! Book value has compounded by 11% annually for over 16 years now despite the excess cash. This is actually a reasonable business. Insiders are all in their sixties / seventies, have been working for 30+ years and own 52% of the company. At some point within a few years they will unlock the value on the balance sheet and the stock will react. Key question is whether that is worth waiting for. Link to comment Share on other sites More sharing options...
KJP Posted December 31, 2016 Share Posted December 31, 2016 Yes, that's the bear case. The bull case is that you get the business for free! Book value has compounded by 11% annually for over 16 years now despite the excess cash. This is actually a reasonable business. Insiders are all in their sixties / seventies, have been working for 30+ years and own 52% of the company. At some point within a few years they will unlock the value on the balance sheet and the stock will react. Key question is whether that is worth waiting for. I think the business itself is fine. But excess cash has been building for many years. The bigger the cash pile is -- particularly in a low-rate environment -- the harder it is to keep compounding book value at double-digit CAGR. That's why I think that, even assuming no change in the underlying business, historical book value CAGR is not a good proxy for future CAGR of book value unless capital allocation changes. I would say the same thing about other nano-caps with similar capital allocation policies and no reasonable likelihood of activism, like George Risk, though that company has started a dividend that partially addresses the issue. I also question whether you get the business for free. I assume you mean that the company's current cash and cash equivalents essentially equals its market cap. But cash on the company's balance sheet is not cash in your pocket. What is $1 of cash on PD-RX's balance sheet actually worth today to a minority shareholder who has no reasonable expectation that the cash will either be (i) paid out anytime soon; or (ii) put to productive use by the company? You are right, though, that a buyer at today's prices should do well if the business were sold relatively soon. If you could find a basket of companies like this with old founder-owners and no heirs in the business, I think you'd do well over time. Link to comment Share on other sites More sharing options...
writser Posted December 31, 2016 Share Posted December 31, 2016 I would add that the excess cash is a relatively new 'problem'. Just three years ago they had 4m in cash, 5m in receivables and 3m in liabilities. Which I would call (too) conservative, but not exactly cash hoarding - especially considering annual revenues are 25m+. The older these guys get and the more cash PD-RX accumulates, the bigger their incentive to do something with it. Until then PD-RX is a savings account that yields 5% - not bad. Also, "the company is currently beginning and evaluating new opportunities which will dictate capital allocation for the next year. At an appropriate time the board will consider the cash demands of those opportunities and other capital allocations for the next two years.". I would not be surprised to see something happening this year or the year after that. Seems unlikely they will spend all their money on a reckless acquisition after running this company conservatively for 30 years. My best guess would be a few investments in the business and a small dividend. That said, this is not my best idea but it seems like a safe place to park some money for patient investors. Link to comment Share on other sites More sharing options...
KJP Posted December 31, 2016 Share Posted December 31, 2016 That said, this is not my best idea but it seems like a safe place to park some money for patient investors. Despite my bellyaching on this thread, I largely agree and still hold. Link to comment Share on other sites More sharing options...
Tim Eriksen Posted June 5, 2017 Share Posted June 5, 2017 OKLAHOMA CITY, June 5, 2017 /PRNewswire/ -- The Board of Directors of PD-Rx Pharmaceuticals, Inc., a publicly held corporation, (Symbol: PDRX) today announced that it has declared a one-time dividend of $.30 per share payable on June 7, 2017 to shareholders of record at the close of business May 31, 2017. This dividend represents a 5% projected annual yield utilizing the May 11, 2017 closing market price of $5.75. Link to comment Share on other sites More sharing options...
Partner24 Posted June 5, 2017 Share Posted June 5, 2017 Still a cheap stock in wich I hold a significant % of my portfolio. Great balance sheet. Cash flow positive. Conservatively managed. A stock buyback would have been a good choice, but I guess that the stock is so illiquid it would have been tought to do that. So a dividend make sense. Cheers! Link to comment Share on other sites More sharing options...
writser Posted June 5, 2017 Share Posted June 5, 2017 Yes, good to see. Link to comment Share on other sites More sharing options...
jawn619 Posted June 6, 2017 Share Posted June 6, 2017 I talked with management. They said they would sell the company for 1.5x Sales. I told them they would never get that price. Link to comment Share on other sites More sharing options...
oddballstocks Posted June 6, 2017 Share Posted June 6, 2017 I talked with management. They said they would sell the company for 1.5x Sales. I told them they would never get that price. I'm guessing you've never sold a company. This is how you do the dance. The great news here is management gave a number. That says they've thought of this, and they have a price they'd take. Companies that aren't willing to throw out something/anything aren't worth talking to. This is on both sides of the table. Don't ever waste your time trying to sell a company to another company that won't name a price. A fixed price is always the starting point, from there it's negotiated. Maybe 1.5x sales isn't that crazy. There are a lot of these small companies that sell at crazy multiples to a strategic acquirer. Think of this as if you were purchasing a tuck-in. You could take out 30% or more of the expenses and at that point you're looking at maybe 2m in net income, is 15x that crazy? Doesn't seem like it. Link to comment Share on other sites More sharing options...
Sharad Posted June 6, 2017 Share Posted June 6, 2017 I talked with management. They said they would sell the company for 1.5x Sales. I told them they would never get that price. I'm guessing you've never sold a company. This is how you do the dance. The great news here is management gave a number. That says they've thought of this, and they have a price they'd take. Companies that aren't willing to throw out something/anything aren't worth talking to. This is on both sides of the table. Don't ever waste your time trying to sell a company to another company that won't name a price. A fixed price is always the starting point, from there it's negotiated. Maybe 1.5x sales isn't that crazy. There are a lot of these small companies that sell at crazy multiples to a strategic acquirer. Think of this as if you were purchasing a tuck-in. You could take out 30% or more of the expenses and at that point you're looking at maybe 2m in net income, is 15x that crazy? Doesn't seem like it. I used to be an investor in PD-RX (I found it via discussions on your blog, oddball - what a find!). However, in 2014, what struck me as odd was the concentration of revenue from one "product" of 49%. I tried to dig around on this, and I believe it was a government contract that wasn't renewed, or renewed at a much reduced rate (below the threshold for disclosure on the DoD website). Here is the contract that was awarded in 2013: http://www.veteranstodayarchives.com/2012/06/28/u-s-department-of-defense-contract-awards-131/ Here is the contract that was awarded in 2014: http://www.militaryindustrialcomplex.com/contract_detail.asp?contract_id=23788 As I mentioned, since 2014, I couldn't find an announcement anywhere regarding a renewal of said contract, and per the notes to the financials, the revenue generated from the concentration of revenue has greatly reduced. Therefore, I moved past this company (it's too difficult and time-consuming to build a big position), but my assumption is that these big contract awards propped up the normal revenue stream of the company, and they have been very inconsistent over the last few years (in terms of magnitude of the contracts), and the government has decided to spread their procurement to multiple suppliers, or reduced their demand for the pharma products they procured from PD-RX. The dividend is nice, but I too agree that the 1.5x sales price tag seems high given the dependence on government contracts. Link to comment Share on other sites More sharing options...
watsa_is_a_randian_hero Posted June 13, 2017 Share Posted June 13, 2017 on the dividend - have others received it? The press release indicated payable on June 7, but interactive brokers still shows the dividend as "accrued" in my account and not yet paid. Link to comment Share on other sites More sharing options...
Tim Eriksen Posted June 13, 2017 Share Posted June 13, 2017 I used to be an investor in PD-RX (I found it via discussions on your blog, oddball - what a find!). However, in 2014, what struck me as odd was the concentration of revenue from one "product" of 49%. I tried to dig around on this, and I believe it was a government contract that wasn't renewed, or renewed at a much reduced rate (below the threshold for disclosure on the DoD website). Here is the contract that was awarded in 2013: http://www.veteranstodayarchives.com/2012/06/28/u-s-department-of-defense-contract-awards-131/ Here is the contract that was awarded in 2014: http://www.militaryindustrialcomplex.com/contract_detail.asp?contract_id=23788 As I mentioned, since 2014, I couldn't find an announcement anywhere regarding a renewal of said contract, and per the notes to the financials, the revenue generated from the concentration of revenue has greatly reduced. Therefore, I moved past this company (it's too difficult and time-consuming to build a big position), but my assumption is that these big contract awards propped up the normal revenue stream of the company, and they have been very inconsistent over the last few years (in terms of magnitude of the contracts), and the government has decided to spread their procurement to multiple suppliers, or reduced their demand for the pharma products they procured from PD-RX. The dividend is nice, but I too agree that the 1.5x sales price tag seems high given the dependence on government contracts. Per my notes, I called them about this back in 2013 or 2014. They told me the government contract had no meaningful revenue in 2013. If you read the release that makes sense. "The award is a fixed-price with economic price adjustment, indefinite-delivery/indefinite-quantity contract with a maximum $46,491,184 to provide pharmaceutical surge, re-supply and sustainment material." Indefinite delivery and quantity sound like a contract for some potential scenario that may or may not happen. I assume the government had a contract in place in case of some type of emergency/terrorist act. The 2015 annual report said the decline in sales was due to the loss of a single drug that they would not name. I don't think it had anything to do with the government contract. As for the 1.5x sales, it does seem high, but some little companies spend a lot on SG&A that is really management perks, so you never know until you do due diligence. Link to comment Share on other sites More sharing options...
Hielko Posted June 13, 2017 Share Posted June 13, 2017 on the dividend - have others received it? The press release indicated payable on June 7, but interactive brokers still shows the dividend as "accrued" in my account and not yet paid. Not paid here either. I think they ran into some problems with the FINRA because announcing a dividend after the ex-date is not okay. No idea how this will be resolved though, my guess is that the stock is now still not trading ex-div (despite what IB is showing). Link to comment Share on other sites More sharing options...
Hielko Posted June 14, 2017 Share Posted June 14, 2017 Dividend just got paid yesterday, seems it is back dated so it was payed a week ago effectively. Link to comment Share on other sites More sharing options...
watsa_is_a_randian_hero Posted December 18, 2017 Share Posted December 18, 2017 does anyone know when the financials are due out? Link to comment Share on other sites More sharing options...
watsa_is_a_randian_hero Posted December 23, 2017 Share Posted December 23, 2017 does anyone know when the financials are due out? anyone out there still? these appear to be overdue Link to comment Share on other sites More sharing options...
bookie71 Posted December 23, 2017 Share Posted December 23, 2017 They appear to come out in late Dec or early Jan Link to comment Share on other sites More sharing options...
bookie71 Posted December 28, 2017 Share Posted December 28, 2017 It is out http://ftp.pdrx.com/docs/2017AuditorsReport.pdf Link to comment Share on other sites More sharing options...
Partner24 Posted December 28, 2017 Share Posted December 28, 2017 A very very cheap stock. Lot of cash, low debt, generate free cash. Gives dividends. Conservative. But in the end, what will they do with that pile of cash? Stock buybacks? Dividends? Expanding the business? Keep it indefinitely? Link to comment Share on other sites More sharing options...
aalexa1225 Posted December 28, 2017 Share Posted December 28, 2017 Anyone know what insider ownership looks like? Link to comment Share on other sites More sharing options...
Jurgis Posted December 28, 2017 Share Posted December 28, 2017 Anyone know what insider ownership looks like? I was going to check on OTC markets, but they say Pink/No Info, so I did not dig further, since I won't be able to buy it anyway: https://www.otcmarkets.com/stock/PDRX/quote Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now